 | | PRD_000907 | | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-4-methyl-1-oxopentan-2-yl]-L-leucinamide | | Formula: | C26 H41 N3 O5 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_001043 | | Name: | (2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-oxo-3-(pentylamino)propyl]butanamide | | Formula: | C14 H28 N2 O4 | | Definition date: | 2013-04-10 | | Last modified: | 2013-04-10 |
|
 | | PRD_000889 | | Name: | (2R,4R)-4-methyl-1-(N~2~-{[(3S)-3-methyl-1,2,3,4-tetrahydroquinolin-8-yl]sulfonyl}-L-arginyl)piperidine-2-carboxylic
acid | | Formula: | C23 H36 N6 O5 S | | Definition date: | 2013-03-13 | | Last modified: | 2013-03-13 |
|
 | | PRD_000830 | | Name: | N-[(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-alpha-glutamyl-L-alpha-glutamine | | Formula: | C35 H35 Br Cl N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000865 | | Name: | N-[(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-{[3-(3'-chlorobiphenyl-4-yl)-1,2-oxazol-5-yl]methyl}propanoyl]-L-a
lanyl-L-alaninamide | | Formula: | C31 H31 Br Cl N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000866 | | Name: | N-{(2S)-3-[(S)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alpha-glutamyl-L-al
pha-glutamine | | Formula: | C29 H32 Br N4 O10 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000868 | | Name: | N-{(2S)-3-[(R)-(4-bromophenyl)(hydroxy)phosphoryl]-2-[(3-phenyl-1,2-oxazol-5-yl)methyl]propanoyl}-L-alanyl-L-alaninamid
e | | Formula: | C25 H28 Br N4 O6 P | | Definition date: | 2013-02-06 | | Last modified: | 2013-02-06 |
|
 | | PRD_000979 | | Name: | N3Phe-Leu-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C33 H49 N7 O5 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000992 | | Name: | HMB-Val-Ser-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C28 H40 N4 O7 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000993 | | Name: | N3Phe-Phe(4-NH2CH2)-Leu-Phe(4-NH2CH2)-methyl vinyl sulfone, bound form | | Formula: | C37 H50 N8 O5 S | | Definition date: | 2013-01-30 | | Last modified: | 2013-01-30 |
|
 | | PRD_000908 | | Name: | N-(3-carboxypropanoyl)-L-valyl-N-[(1S)-2-phenyl-1-phosphonoethyl]-L-prolinamide | | Formula: | C22 H32 N3 O8 P | | Definition date: | 2013-01-23 | | Last modified: | 2013-01-23 |
|
 | | PRD_000958 | | Name: | tert-butyl {(2S)-1-[(1R,2S,5S)-2-{[(2S,3R)-4-amino-1-cyclopropyl-3-hydroxy-4-oxobutan-2-yl]carbamoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hex-3-yl]-3,3-dimethyl-1-oxobutan-2-yl}carbamate | | Formula: | C26 H44 N4 O6 | | Definition date: | 2012-12-26 | | Last modified: | 2012-12-26 |
|
 | | PRD_000900 | | Name: | N-(benzylsulfonyl)-D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | | Formula: | C26 H35 N5 O4 S | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000919 | | Name: | N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide | | Formula: | C19 H37 N5 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000920 | | Name: | SAMAROSPORIN I | | Formula: | C77 H120 N16 O19 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000944 | | Name: | N-{(2S)-1-[(2-chlorobenzyl)amino]-1-oxo-4-phenylbutan-2-yl}-N~2~-[3-(2-methylphenyl)propanoyl]-L-threoninamide | | Formula: | C31 H36 Cl N3 O4 | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000946 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-isoleucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000947 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(cyclohexylmethyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C31 H35 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000948 | | Name: | N-{(2S,3R)-4-[(1,3-benzothiazol-6-ylsulfonyl)(3-phenylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-3-hydroxybenzamide | | Formula: | C33 H33 N3 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000949 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-([(2S)-2-methylbutyl]{[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino)-1-phenylbutan-2-yl]benzamide | | Formula: | C29 H33 N3 O6 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000950 | | Name: | N~2~-acetyl-N-[(2S,3R)-4-{(1,3-benzothiazol-6-ylsulfonyl)[(2S)-2-methylbutyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-L-leucinamide | | Formula: | C30 H42 N4 O5 S2 | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000951 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]benzamide | | Formula: | C28 H34 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000952 | | Name: | N~2~-acetyl-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]-L-isoleucinamide | | Formula: | C29 H43 N3 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000953 | | Name: | N-[(2S,3R)-4-{(cyclohexylmethyl)[(4-methoxyphenyl)sulfonyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-3-hydroxybenzamide | | Formula: | C31 H38 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
 | | PRD_000954 | | Name: | 3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](3-phenylpropyl)amino}-1-phenylbutan-2-yl]benzamide | | Formula: | C33 H36 N2 O6 S | | Description: | SYNTHETIC HIV-1 PROTEASE INHIBITOR | | Definition date: | 2012-12-12 | | Last modified: | 2012-12-12 |
|
